MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jval.2026.03.2267

Медицинская библиотека · Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2026

Evaluating the cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: the UK-ROX trial.

Zhu Zhengnan, Martin Daniel, Cowden Alex, Gould Doug, Grocott Michael P W, Shahid Tasnin, Harrison David, Rowan Kathryn M, Mouncey Paul, Sadique Zia, UK-ROX investigators. Electronic address: zia.sadique@lshtm.ac.uk, UK-ROX investigators

СтатьяПеревод в очереди

Аннотация

OBJECTIVES

There is a lack of economic evaluation evidence on the optimal oxygen dosing level for mechanically ventilated critically ill patients. This study reports the health economic outcomes of a large-scale randomized controlled trial (RCT), UK-ROX, and conducts a full cost-effectiveness analysis of conservative versus usual oxygen therapy.

METHODS

All-cause mortality, health related quality of life (HrQoL), quality-adjusted life-years (QALYs), costs, and incremental net monetary benefit (INB) were assessed at 90 days post-randomization. HrQoL was derived from information collected via an EQ-5D-5L questionnaire using an appropriate mapping function. Total healthcare costs include resource use that occurred in adult ICUs, general wards, and follow-up health services. The cost effectiveness analysis (CEA) used regression methods to report the cost-effectiveness and summarised the uncertainties around the incremental cost-effectiveness results.

RESULTS

After adjustment for prespecified baseline variables, the estimated incremental costs of conservative oxygen therapy versus usual oxygen therapy were -£968 (95% CI -£2279 to £342). The adjusted mean differences in EQ-5D utility score and life-years were 0.004 (95% CI -0.016 to 0.025) and -0.003 (95% CI -0.006 to 0.001), and incremental QALYs were 0.001 (95% CI -0.002 to 0.003). As a result, the mean INB of conservative oxygen therapy was £979 (95% CI -£334 to £2292).

CONCLUSIONS

Conservative and usual oxygen therapy resulted in similar QALYs, and while conservative therapy appeared cost-saving with positive INBs, both estimates have uncertainty.

Для цитирования: Zhu Zhengnan, Martin Daniel, Cowden Alex, Gould Doug, Grocott Michael P W, Shahid Tasnin, Harrison David, Rowan Kathryn M, Mouncey Paul, Sadique Zia, UK-ROX investigators. Electronic address: zia.sadique@lshtm.ac.uk, UK-ROX investigators. Evaluating the cost-effectiveness of a conservative approach to oxygen therapy for invasively ventilated adults in intensive care: the UK-ROX trial.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2026. DOI: 10.1016/j.jval.2026.03.2267.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.